Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Leukemia-Related Protein is a Master Editor of the "Histone Code"

28.11.2002


Rearrangements of the mixed lineage leukemia gene, MLL, are associated with aggressive leukemias in both children and adults. Researchers at the University of Pennsylvania School of Medicine have found that one portion of the MLL protein is an enzyme that "edits" the so-called histone code, a series of modifications to proteins associated with DNA that influence how and when certain genes are turned on and off. Their findings are presented in the November issue of Molecular Cell.



When functioning properly, the MLL protein regulates the expression of Hox genes, which play a role in cell growth and development. In some leukemias MLL is rearranged so that the cells are unable to turn off Hox genes. The Penn investigators found that a portion of the MLL protein binds directly to the Hox genes and edits the histone code at these sites. A rearranged form of MLL that causes leukemia also upregulated Hox expression but with a different "code". Presumably the differences in the pattern of histone modifications accounts for their deregulated expression in leukemia.

The histone code hypothesis was first outlined by Dr. C. David Allis and colleagues, of the University of Virginia Health System, a co-author on this paper. The theory, which rapidly is gaining acceptance, postulates that expression of certain regions of DNA is turned on and off by modifying portions of histone proteins or DNA. Modified histones and DNA attract the cell’s gene-reading machinery via specific interactions with these elements of the histone code.


According to Jay L. Hess MD, PhD, of Penn’s Department of Pathology and Laboratory Medicine and senior author of the study, these results underscore the importance of the histone code in developmental biology and disease. "Domains similar to those with histone modifying activity in MLL are found in other proteins implicated in human tumors including acute leukemia, lymphoma, and prostate cancer and probably have a similar function. What is encouraging is that proteins with enzymatic activity are good targets for drug development. These are definitely exciting times for cancer biologists."

This study was supported by grants from the Leukemia and Lymphoma Society, the National Institutes of Health, the Natural Sciences and Engineering Research Council of Canada, and the Genetics Institute of the Canadian Institute for Health Research.

Co-authors of this study include Tom Milne, Denise Gibbs, and Mary Ellen Martin, of Penn, Scott D. Briggs and C. David Allis of the University of Virginia Health System, and Hugh Brock of the University of British Columbia.

Greg Lester | EurekAlert!
Further information:
http://www.uphs.upenn.edu/news/

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>